NICOLE KYRIAKOS: Open Payments
NPI 1760658165 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$378 in 17 payments from 8 companies in 2025. Trend: 2023 $475 · 2024 $728 · 2025 $378
Food & beverage: $378
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $88 |
| Novo Nordisk Inc | 3 | $74 |
| Lilly USA, LLC | 2 | $54 |
| PFIZER INC. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Corcept Therapeutics | 1 | $31 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $20 |
Products named: EVENITY, Ozempic, ELIQUIS, Korlym, MOUNJARO, INJECTAFER, JARDIANCE, Rybelsus.
Industry payments across MD — which companies pay providers there.
